Canlyniadau Chwilio - Martin Höglund

Mireinio'r Canlyniadau
  1. 1
    National and regional incidence of surgery for adult hydrocephalus in Sweden

    National and regional incidence of surgery for adult hydrocephalus in Sweden gan Magnus Tisell, Martin Höglund, Carsten Wikkelsø

    Cyhoeddwyd 2005
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Acute myeloid leukemia in the real world: why population-based registries are needed

    Acute myeloid leukemia in the real world: why population-based registries are needed gan Gunnar Juliusson, Vladimir Lazarević, Ann‐Sofi Hörstedt, Oskar Hagberg, Martin Höglund

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population

    Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population gan Hannah Bower, Magnus Björkholm, Paul W. Dickman, Martin Höglund, Paul C. Lambert, Therése Andersson

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Sex Differences in Fertility-Related Information Received by Young Adult Cancer Survivors

    Sex Differences in Fertility-Related Information Received by Young Adult Cancer Survivors gan Gabriela Armuand, Kenny A. Rodriguez‐Wallberg, Lena Wettergren, Johan Ahlgren, Gunilla Enblad, Martin Höglund, Claudia Lampic

    Cyhoeddwyd 2012
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

    Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry gan Gunnar Juliusson, Petar Antunović, Åsa Rangert Derolf, Sylvain Lehmann, Lars Möllgård, Dick Stockelberg, Ulf Tidefelt, Anders Wåhlin, Martin Höglund

    Cyhoeddwyd 2008
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis

    Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis gan Mohamed Ali Mosrati, Kerstin Willander, Ingrid Jakobsen Falk, Monica Hermanson, Martin Höglund, Dick Stockelberg, Yuan Wei, Kourosh Lotfi, Peter Söderkvist

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by<i>DNMT3A</i>mutational status and associated with predominant hypomethylation of HOX genes

    Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by<i>DNMT3A</i>mutational status and associated with predominant hypomethylation of HOX ge... gan Ying Qu, Andreas Lennartsson, Verena I. Gaidzik, Stefan Deneberg, Mohsen Karimi, Sofia Bengtzén, Martin Höglund, Lars Bullinger, Konstanze Döhner, Sören Lehmann

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia

    Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia gan Anna Eriksson, Albin Österroos, Syed Shams ul Hassan, Joachim Gullbo, Linda Rickardson, Malin Jarvius, Peter Nygren, Mårten Fryknäs, Martin Höglund, Rolf Larsson

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting

    The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting gan Gunnar Juliusson, Martin Jädersten, Stefan Deneberg, Sören Lehmann, Lars Möllgård, Lovisa Wennström, Petar Antunović, Jörg Cammenga, Fryderyk Lorenz, Emma Ölander, Vladimir Lazarević, Martin Höglund

    Cyhoeddwyd 2020
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses

    The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses gan Lisa Christiansson, Stina Söderlund, Sara M. Mangsbo, Henrik Hjorth‐Hansen, Martin Höglund, Berit Markevärn, Johan Richter, Leif Stenke, Satu Mustjoki, Angelica Loskog, Ulla Olsson‐Strömberg

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry

    Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry gan Anna Lübking, Arta Dreimane, Fredrik Sandin, Cecilia Isaksson, Berit Markevärn, Mats Brune, Per Ljungman, Stig Lenhoff, Leif Stenke, Martin Höglund, Johan Richter, Ulla Olsson‐Strömberg

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era

    Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era gan Niklas Gunnarsson, Leif Stenke, Martin Höglund, Fredrik Sandin, Magnus Björkholm, Arta Dreimane, Mats Lambe, Berit Markevärn, Ulla Olsson‐Strömberg, Johan Richter, Hans Wadenvik, Jonas Wallvik, Anders Själander

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008

    Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008 gan Magnus Björkholm, Lotta Ohm, Sandra Eloranta, Åsa Rangert Derolf, Malin Hultcrantz, Jan Sjöberg, Therése Andersson, Martin Höglund, Johan Richter, Ola Landgren, Sigurður Y. Kristinsson, Paul W. Dickman

    Cyhoeddwyd 2011
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Hematopoietic stem cell transplantation rates and long‐term survival in acute myeloid and lymphoblastic leukemia

    Hematopoietic stem cell transplantation rates and long‐term survival in acute myeloid and lymphoblastic leukemia gan Gunnar Juliusson, Karin Karlsson, Vladimir Lazarević, Anders Wåhlin, Mats Brune, Petar Antunović, Åsa Rangert Derolf, Hans Hägglund, Holger Karbach, Sören Lehmann, Lars Möllgård, Dick Stockelberg, Heléne Hallböök, Martin Höglund

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: A report from the Swedish Acute Leukemia Registry

    Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: A report from the Swedish Acute Leukemia Registry gan Erik Hulegårdh, Christer Nilsson, Vladimir Lazarević, Hege Garelius, Petar Antunović, Åsa Rangert Derolf, Lars Möllgård, Bertil Uggla, Lovisa Wennström, Anders Wåhlin, Martin Höglund, Gunnar Juliusson, Dick Stockelberg, Sören Lehmann

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period

    Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period gan Gunnar Juliusson, Oskar Hagberg, Vladimir Lazarević, Emma Ölander, Petar Antunović, Jörg Cammenga, Lovisa Wennström, Lars Möllgård, Mats Brune, Martin Jädersten, Stefan Deneberg, Sören Lehmann, Åsa Rangert Derolf, Martin Höglund

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Carta
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks

    Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks gan Stefan Deneberg, Philippe Guardiola, Andreas Lennartsson, Ying Qu, Verena Gaidzik, Odile Blanchet, Mohsen Karimi, Sofia Bengtzén, Hareth Nahi, Bertil Uggla, Ulf Tidefelt, Martin Höglund, Christer Paul, Karl Ekwall, Konstanze Döhner, Sylvain Lehmann

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

    A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia gan Gunilla Enblad, Hannah Karlsson, Gustav Gammelgård, Jessica Wenthe, Tanja Lövgren, Rose‐Marie Amini, Kristina Wikström, Magnus Essand, Barbara Savoldo, Heléne Hallböök, Martin Höglund, Gianpietro Dotti, Malcolm K. Brenner, Hans Hagberg, Angelica Loskog

    Cyhoeddwyd 2018
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experience

    Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experience gan Vladimir Lazarević, A-S Hörstedt, Bertil Johansson, P Antunović, Rolf Billström, Åsa Rangert Derolf, Erik Hulegårdh, Sören Lehmann, Lars Möllgård, Christer Nilsson, Stefan Peterson, Dick Stockelberg, Bertil Uggla, Lovisa Wennström, Anders Wåhlin, Martin Höglund, Gunnar Juliusson

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications

    Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications gan Christer Nilsson, Fredrika Linde, Erik Hulegårdh, Hege Garelius, Vladimir Lazarević, Petar Antunović, Jörg Cammenga, Stefan Deneberg, Anna Eriksson, Martin Jädersten, Cecilia Kämpe Björkvall, Lars Möllgård, Lovisa Wennström, Emma Ölander, Martin Höglund, Gunnar Juliusson, Sören Lehmann

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: